Talaris Therapeutics, Inc. has been dropped from NASDAQ Biotechnology Index.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.84 USD | -1.03% | +2.01% | -39.80% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.80% | 410M | |
-2.16% | 103B | |
+0.36% | 95.71B | |
+1.69% | 22.02B | |
-16.67% | 20.9B | |
-9.30% | 17.85B | |
-42.83% | 16.21B | |
-15.15% | 15.52B | |
+3.51% | 13.86B | |
+33.79% | 12.04B |
- Stock Market
- Equities
- TRML Stock
- News Tourmaline Bio, Inc.
- Talaris Therapeutics, Inc.(NasdaqGM: TALS) dropped from NASDAQ Biotechnology Index